The same biochemical triggers that spur a “fight or flight” response when we encounter threats may help tumor cells to thrive.
Shalana O'Brien, MD, is a highly skilled surgical oncologist treating patients with melanoma/skin cancers, endocrine disorders and cancers, and specializing in heated chemotherapy (HIPEC) to treat advanced cancers that have spread within the abdomen.
A central question in oncology is how to offer efficacious treatments while minimizing toxicity. This is especially true when treating advanced sarcoma and melanoma of the extremity.
New findings could lead to better tools for the identification of at-risk individuals, earlier cancer prevention.
JAMA Oncology provides new insights that survival benefits are held regardless of BRAF mutation status or earlier targeted therapy.
This site is intended for healthcare professionals